BioSpace News Archive

IRLAB Increases its Liquidity with a Loan Facility of Up to SEK 55 Million that Extends Financial Runway and Increases Business Opportunities

IRLAB Therapeutics, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company has entered into a loan agreement of up to SEK 55 million issued by Formue Nord Fokus A/S.

December 22, 2023
·
3 min read
Policy

FDA Roundup: December 22, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

December 22, 2023
·
5 min read
Pharm Country

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - December 22, 2023

Madrigal Pharmaceuticals, Inc. announced that the company granted equity awards to thirty-two new employees with a grant date of December 19, 2023 as equity inducement awards outside of the Company’s Amended 2015 Stock Plan under the terms of the company’s 2023 Inducement Plan.

December 22, 2023
·
1 min read
Pharm Country

Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023

Cellectis held a shareholders general meeting at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.

December 22, 2023
·
5 min read
Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering

Alpha Cognition Inc. announces that it has completed a fourth closing pursuant to its previously announced private placement of units of the Company. Pursuant to the fourth closing, the Company issued 9,141,534 units of the Company at a price of US$0.22 per unit for gross proceeds of US$2,011,138.

December 22, 2023
·
1 min read
Pharm Country

Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023

Aptorum Group Limited provided a business update and announced financial results for the six months ended June 30, 2023.

December 22, 2023
·
14 min read